Yinnong Jia
Visiting Scholar
Research interest
Receptor targeting, multimodal imaging probes, antiviral treatment, peptide-based radiopharmaceutics and theranostics
Work Experience
2017-Present, Associate Prof., Kunming Medical University
Education Background
Ph.D., Pharmaceutical Sciences, University of Nebraska Medical Center, United States, 2017
B.Sc. Pharmaceutical Sciences, Shenyang Pharmaceutical University, China, 2011
E-mail: jiayinnong@kmmu.edu.cn
Publication
Yang T, Gao W, Ma X, Liu Q, Pang P, Zheng Y, Jia Y#, Zheng C#. A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection. Viruses 2024, 16, 365. https://doi.org/10.3390/v16030365
Wu J, Yuan S, Jiang Y, Jia Y#, Ji C, Tan Z, Shi W, Peng Z#. Alendronate-derived carbon dots for bioimaging and effective osteoblastic differentiation induction and promotion. Diamond and Related Materials. 2023;140. 110571.
Jiang Y, Tan Z, Zhao T, Wu J, Li Y, Jia Y #, Peng Z#.Indocyanine Green derived Carbon Dots with Significantly Enhanced Properties for Efficient Photothermal Therapy, Nanoscale, 2023, 15(4): 1925-1936.
Ma X*, Jia Y*, Yuan J, Tang Q, Gao W, Zhou G, Yang R, Pang W, Zheng C. Inhibiting cardiac autophagy suppresses Zika virus replication. J Med Virol. 2023; 95:e28483.
Gao Y*, Jia Y*, Yu Z, Ji X, Liu X, Han L, Zhang H, Zhu B, Xu M. Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database. Eur J Med Res 28, 103 (2023).
Tan Z, Sun W, Li Y, Jiao X, Zhu M, Zhang J, Qing C, Jia Y. Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis, Biomolecules, 2022, 12: 1273.
Tan Z, Huang H, Sun W, Li Y, Jia Y. Current progress of ferroptosis study in ovarian cancer. Front Mol Biosci. 2022 Aug 26;9:966007.
Jia Y, Zhang W, Fan W, Brusnahan S, Garrison J. Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide. Bioconjugate Chemistry. 2016,27(11), pp 2658–2668.
Jia Y, Shi W, Zhou Z, Wagh N, Fan W, Brusnahan S, Garrison J. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting. Nuclear medicine and biology. 2015; 42(11), 816-823.
Research Grants:
National Nature Science Foundation of China, Development and evaluation of a novel Lu-177 radiolabelled neurotension for tumor targeting therapy, 01/2022-12/2025, host.
Yunnan Youth Talents Foundation, Radiolabelled probe for the theranostic of prevalent tumors in Yunnan, 01/2021-12/2025, host.
Awards:
Best presentation award of Annual health research international conference at Thailand (instructor), 2022
National college students research English competition- Grand Prize (instructor), 2022
The talent program of Yunnan province –Young talent investigator, 2019
Outstanding research paper, annual national oncology and pharmacology meeting, 2019
First place poster, SNMMI (Society of Nuclear Medicine and Molecular Imaging) annual meeting, 2015
UNMC Vital U achievement, 2017
Presentations:
Yinnong Jia, 2022. 1st annual health research international conference, Songkhla, Thailand (Session report)
Yinnong Jia, 2020. Chinese society of nuclear medicine annual meeting, Shijiazhuang, Hebei (Session report)
Yinnong Jia, 2020. 15th Annual National Conference on Radiopharmaceuticals and Labeled Compounds, Chengdu, Sichuan (Poster)
Yinnong Jia, 2019. 16th Annual tumor pharmacology meeting, Xi’an, Shanxi (Session report)
Yinnong Jia, 2016. 48th Pharmaceutics Graduate Student Research Meeting, Kansas City, MO. (Oral)
Yinnong Jia, 2016. Annual COBRE meeting, Nebraska City, NE (Oral)
Yinnong Jia, 2016. Annual SNMMI Meeeting, San Diego, CA. (Poster)
Yinnong Jia, 2016 Annual Biopharmaceutical R&D Symposium, Omaha, NE. (Oral and Poster)
Yinnong Jia, 2015. Annual SNMMI Meeeting, Baltimore, MD. (Poster)
Yinnong Jia, 2015. 47th Pharmaceutics Graduate Student Research Meeting, Lexington, KY. (Poster)